ADHD Trial, Recruiting NCT04532190 Sponsor: University of Calgary Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT04532190
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with ADHD
  • You are between 9 and 15 years old
  • You have an IQ score above 80 (confirm with trial site)
  • You can read, write, and speak English well enough to give your agreement to participate
  • If you are currently taking medication for ADHD, you have been on the same medication and dose for at least 3 months

Who may not be able to join:

  • You have been diagnosed with mania, psychosis, or bipolar disorder
  • You have any metal implants in your body, such as a pacemaker or metal plates, which could interfere with brain scanning (MRI) or brain stimulation (TMS) procedures
  • You have previously had electroconvulsive therapy (ECT) or vagus nerve stimulation treatment
  • You have been diagnosed with Autism Spectrum Disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Calgary
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

TEACH-2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov